W e appreciate Dr. Erol's (1) interest in our article describing the phenotype of fat cellspecific rictor knockout (FRic 2/2 ) mice (2). Dr. Erol suggested that RBP4 may play a role in the development of insulin resistance in FRic 2/2 mice. RBP4 is an adipokine, whose elevated expression in, and secretion from, adipocytes correlates with the development of insulin resistance in various animal models including the fat cell-specific GLUT4 knockout (G4A 2/2 ) mice (3). Elevated circulating levels of RBP4 have also been demonstrated in insulin-resistant obese subjects and type 2 diabetic patients (4). Although a role for adipocyte-RBP4 as a regulator of whole-body insulin sensitivity is suggested, little is known about the regulation of the expression and secretion of RBP4 in adipocytes.
We agree that loss of adipocyte GLUT4 in G4A 2/2 mice (3) and decreased GLUT4 expression in insulin-resistant human subjects (3, 4) are associated with an increase in expression and secretion of RBP4. However, it is not known whether the adipocyte-RBP4 response is caused by the reduction in total GLUT4 levels or because of the resulting decrease in insulin-stimulated glucose influx. We did not measure whether RBP4 was altered in FRic 2/2 mice. However, we do not think that RBP4 is the cause of the systemic insulin resistance that was observed in FRic 2/2 mice. Insulin-stimulated glucose uptake is impaired in FRic 2/2 adipocytes because of changes in insulin signaling and defective GLUT4 translocation to the plasma membrane in the absence of rictor (2) . Total GLUT4 levels are not changed in the FRic 2/2 adipocytes (2). The decrease in basal glucose uptake in FRic 2/2 adipocytes (2) does not support Dr. Erol's model whereby decreased insulin-stimulated glucose uptake induces increased basal glucose uptake. In FRic 2/2 mice, loss of rictor expression does not only lead to impaired GLUT4 translocation to the plasma membrane, but multiple other defects (2). Most importantly, FRic 2/2 mice show dysregulation of lipolysis and increased circulating nonesterified fatty acid (2), a condition not observed in G4A 2/2 mice (5). Because it is very well known that an increase in circulating nonesterified fatty acid is sufficient to cause insulin resistance (6) , this finding alone is sufficient to explain the insulin resistance observed in the FRic 2/2 mice.
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